Exactech, Inc. (NASDAQ:EXAC) posted its earnings results on Monday. The medical equipment provider reported $0.20 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.03), Yahoo Finance reports. Exactech had a return on equity of 7.39% and a net margin of 0.30%.

Exactech (NASDAQ:EXAC) traded up 0.060% during mid-day trading on Tuesday, reaching $41.725. The company’s stock had a trading volume of 45,775 shares. The firm has a market capitalization of $598.67 million, a price-to-earnings ratio of 802.404 and a beta of 1.01. The company’s 50-day moving average price is $33.78 and its 200 day moving average price is $30.87. Exactech has a 52 week low of $22.20 and a 52 week high of $42.55.

A number of analysts have weighed in on the company. Robert W. Baird set a $34.00 target price on Exactech and gave the stock a “buy” rating in a report on Sunday, October 15th. BidaskClub upgraded Exactech from a “sell” rating to a “hold” rating in a report on Friday, August 18th. Gabelli restated a “buy” rating on shares of Exactech in a report on Monday, July 31st. Sidoti lowered Exactech from a “buy” rating to a “neutral” rating in a report on Monday, October 23rd. Finally, Zacks Investment Research lowered Exactech from a “hold” rating to a “sell” rating in a report on Wednesday, October 25th. One investment analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. The company has a consensus rating of “Hold” and an average target price of $42.00.

In related news, Director Fern Watts sold 1,013 shares of the business’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $29.04, for a total transaction of $29,417.52. Following the completion of the transaction, the director now owns 4,727 shares in the company, valued at $137,272.08. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 28.30% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/31/exactech-inc-exac-announces-earnings-results.html.

Exactech Company Profile

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Earnings History for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with MarketBeat.com's FREE daily email newsletter.